NKE
NIKE, Inc.
NKE has slightly lower modeled downside risk, despite its lower overall score.
SN
SharkNinja, Inc.
SN has the edge over NKE overall, supported by stronger fundamentals and stronger modeled upside.
NKE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Strong |
NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
SN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Healthy | |
| Strong |
SN's revenue, profitability, cash flow and balance sheet are all currently healthy.
NKE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $37.76 | — |
| Cheap | 23x | $47.70 | +26% |
| Forward | 30x | $37.76 | — |
| Fair | 33x | $68.16 | +80% |
| Expensive | 47x | $97.86 | +159% |
Historical ranges are pointers, not guarantees.
NKE has the edge over SN in the historical PE scenario, which offers more potential upside but is not a forecast.
SN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 26x | $155 | -29% |
| Forward | 30x | $220 | — |
| Fair | 36x | $214 | -2.8% |
| Current | 37x | $220 | — |
| Expensive | 55x | $329 | +50% |
Historical ranges are pointers, not guarantees.
SN's PE is in its fair range at 37x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
NKE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Decline | |
| Improving | |
| Moderate | |
| Low |
Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.
SN Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
SN has the edge over NKE on the outlook, with more favorable valuation and earnings expectations.
NKE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | -39% |
| Q3 2026 | $2.09 | +7.2% |
| Q2 2026 | $2.10 | -2.8% |
| Q1 2026 | $1.51 | -50% |
| Q4 2025 | $1.70 | -48% |
| Q3 2025 | $1.95 | -44% |
| Q2 2025 | $2.16 | -42% |
| Q1 2025 | $3.01 | -11% |
| Q4 2024 | $3.24 | -5.3% |
NKE's earnings per share have fallen from their peak: $2.09 over the past year, against $3.82 in late 2021.
SN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $7.26 | +22% |
| Q3 2026 | $5.96 | +47% |
| Q2 2026 | $4.90 | +34% |
| Q1 2026 | $4.96 | +57% |
| Q4 2025 | $4.94 | +59% |
| Q3 2025 | $4.05 | +59% |
| Q2 2025 | $3.66 | +110% |
| Q1 2025 | $3.16 | +134% |
| Q4 2024 | $3.11 | +159% |
SN has the edge over NKE on earnings, with more consistent year-over-year improvement.
NKE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.2B | -4.3% |
| Q2 2026 | $11B | -1.1% |
| Q1 2026 | $11.3B | +0.1% |
| Q4 2025 | $12.4B | +0.6% |
| Q3 2025 | $11.7B | +1.1% |
| Q2 2025 | $11.1B | -12% |
| Q1 2025 | $11.3B | -9.3% |
| Q4 2024 | $12.4B | -7.7% |
NKE's revenue fell from its 2023 peak and has held roughly level since: $11.2B last quarter, down 4.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +0.3 points |
| Q2 2026 | 12% | +9.2 points |
| Q1 2026 | 5.8% | -1.7 points |
| Q4 2025 | 8% | -3.4 points |
| Q3 2025 | 7.9% | -3.4 points |
| Q2 2025 | 2.9% | -11 points |
| Q1 2025 | 7.5% | -3.8 points |
| Q4 2024 | 11% | -2.9 points |
NKE's operating margin was 8.2% last quarter, about level with the same quarter a year ago.
SN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2B | +21% |
| Q2 2026 | $1.8B | +22% |
| Q1 2026 | $1.4B | +16% |
| Q4 2025 | $2.1B | +18% |
| Q3 2025 | $1.6B | +14% |
| Q2 2025 | $1.4B | +16% |
| Q1 2025 | $1.2B | +15% |
| Q4 2024 | $1.8B | +30% |
SN has the edge over NKE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 22% | +5.9 points |
| Q2 2026 | 10% | -1.5 points |
| Q1 2026 | 12% | -0.2 points |
| Q4 2025 | 16% | +4.9 points |
| Q3 2025 | 17% | +3.9 points |
| Q2 2025 | 12% | +3.3 points |
| Q1 2025 | 12% | -2.8 points |
| Q4 2024 | 11% | +4.2 points |
SN has the edge over NKE on profitability, with a higher operating margin.
NKE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$64M | -527% |
| Q2 2026 | $1.5B | +313% |
| Q1 2026 | $284M | -83% |
| Q4 2025 | $386M | -58% |
| Q3 2025 | $15M | -95% |
| Q2 2025 | $363M | -85% |
| Q1 2025 | $1.7B | -11% |
| Q4 2024 | $920M | -65% |
NKE usually generates cash, though not every quarter: the latest was −$64M, but it generated $2.1B over the past year.
SN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$209.7M | -343% |
| Q2 2026 | $382.6M | +$419.2M |
| Q1 2026 | -$190.2M | -$98.5M |
| Q4 2025 | $523.3M | +19% |
| Q3 2025 | $86.2M | +$151.2M |
| Q2 2025 | -$36.5M | +$57.5M |
| Q1 2025 | -$91.7M | -639% |
| Q4 2024 | $441.4M | +237% |
SN has the edge over NKE on cash flow, with more consistent year-over-year improvement.
NKE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +3.2M shares |
| 1 year | +0.4% | +5.2M shares |
| 3 years | -3.8% | -59.1M shares |
| 5 years | -8.4% | -135M shares |
| Available history | -6.9% | -110M shares |
NKE has 1.5B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $20M |
| Q3 2025 | $126M |
| Q2 2025 | $199M |
| Q1 2025 | $506M |
| Q4 2024 | $1.1B |
NKE has spent almost nothing on buybacks in the past year.
SN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +14.5K shares |
| 1 year | -0.4% | -598K shares |
| 3 years | +1.5% | +2.1M shares |
SN has the edge over NKE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $50.5M |
| Q2 2026 | $100.7M |
| Q1 2026 | $18.5M |
| Q4 2025 | — |
| Q3 2025 | $1.1M |
| Q2 2025 | $788,000 |
| Q1 2025 | $48.4M |
| Q4 2024 | $11.4M |
SN spent $170M buying back its own shares over the past year, up 175% from the year before.
NKE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.2x | Very low |
| Q3 2024 | 0.1x | Very low |
| Q2 2024 | -0.1x | Net Cash |
| Q1 2024 | -0.0x | Very low |
| Q4 2023 | 0.1x | Very low |
NKE's net debt is less than a year of its operating earnings (EBITDA).
SN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | -0.1x | Net Cash |
| Q1 2026 | 0.2x | Very low |
| Q4 2025 | 0.1x | Very low |
| Q3 2025 | 0.7x | Very low |
| Q2 2025 | 0.9x | Very low |
| Q1 2025 | 0.9x | Very low |
| Q4 2024 | 0.8x | Very low |
SN's net debt is less than a year of its operating earnings (EBITDA).
NKE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 57.5 | Neutral |
NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).
SN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 74.4 | Overbought |
| Stochastic | 91.2 | Overbought |
SN's weekly RSI is 74 (overbought) and its Stochastic is 91 (overbought).
NKE PE vs Consumer Cyclical Sector
| Metric | NKE | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.3% above |
| PE % | 2 | 47 | 45 pts below |
NKE has the edge over SN on valuation relative to its sector.
SN PE vs Consumer Cyclical Sector
| Metric | SN | Sector median | Relative |
|---|---|---|---|
| PE | 37x | 18x | 105% above |
| PE % | 52 | 33 | 19 pts above |
SN is trading at 37x earnings, a 105% premium to the Consumer Cyclical sector's median of 18x.
NKE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.7 | 2.8% above |
| 20 week MA | $39.2 | 3.6% below |
| 50 week MA | $48.0 | 21% below |
| 100 week MA | $58.4 | 35% below |
| 200 week MA | $79.2 | 52% below |
SN has stronger trend alignment. NKE is above 1 of 5 weekly averages versus SN above 4 of 4.
SN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $197.4 | 12% above |
| 20 week MA | $179.5 | 23% above |
| 50 week MA | $142.3 | 55% above |
| 100 week MA | $120.7 | 82% above |
SN is in an uptrend: it's above all four of its weekly moving averages, and 82% above its 100-week average.
NKE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $101.6 | $141.6 | +39% |
| 2021 | $141.6 | $165.7 | +17% |
| 2022 | $165.7 | $116.3 | -30% |
| 2023 | $116.3 | $108.6 | -6.6% |
| 2024 | $108.6 | $76.4 | -30% |
| 2025 | $76.4 | $60.9 | -20% |
| 2026 YTD | $60.9 | $37.8 | -38% |
NKE has finished four years in a row lower, and it's down 38% so far in 2026.
SN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $26.9 | $51.2 | +90% |
| 2024 | $51.2 | $97.3 | +90% |
| 2025 | $97.3 | $114.0 | +17% |
| 2026 YTD | $114.0 | $220.1 | +93% |
SN has the edge over NKE on returns for 2026, with the stronger performance.